European Journal of Radiology
Volume 40, Issue 3 , Pages 184-197 , December 2001

Hereditary neuromuscular diseases

  • Ö Özsarlak

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32-3-821-4504; fax: +32-3-825-2026
    • ,
  • E Schepens

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium
    • ,
  • P.M Parizel

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium
    • ,
  • J.W Van Goethem

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium
    • ,
  • F Vanhoenacker

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium
    • ,
  • A.M De Schepper

      Affiliations

    • Department of Radiology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium
    • ,
  • J.J Martin

      Affiliations

    • Department of Neurology, University Hospital Antwerp, Wilrijkstraat 10, B-2650 Edegem, Belgium

Received 16 July 2001 ,Revised 17 July 2001 ,Accepted 18 July 2001.

References 

  1. Bulcke JAL, Herpels V. Diagnostic value of CT scanning in neuromuscular diseases. Radiologe. 1983;23:523–528
  2. Suput D, Zupan A, Sepe A, Demsar F. Discrimination between neuropathy and myopathy by use of magnetic resonance imaging. Acta. Nuerol. Scand. 1993;87:118–123
  3. Neuromuscular conditions covered by the Muscular Dystrophy Campaign, http://www.muscular-dystrophy.org/information/Research/cond.html.
  4. Cordier L, Gao GP, Hack AA, McNally EM, Wilson JM, Chirmule N, et al. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum. Gene Ther. 2001;12:205–215
  5. Termote JL, Baert A, Crolla D, Palmers Y, Bulcke JA. Computed tomography of the normal and pathological muscular system. Radiology. 1980;137:439–444
  6. Swash M, Brown MM, Thakkar C. CT muscle imaging and the clinical assessment of neuromuscular diseases. Muscle Nerve. 1995;18:708–714
  7. De Visser M, Verbeeten B. Computed tomography of the skeletal musculature in Becker-type muscular dystrophy and benign infantile spinal muscular atrophy. Muscle Nerve. 1985;8:435–444
  8. Kawar M, Kunimoto M, Motoyoshi Y. Computed tomography in Duchenne type muscular dystrophy. Morphological stages based on the computed tomographical findings. Clin. Neurol. 1985;25:578–590
  9. vd Vliet AM, Thijssen HOM, Joosten E, Merx JL. CT in neuromuscular disorders: a comparison of CT and histology. Neuroradiology. 1988;30:421–425
  10. Nordal HJ, Dietrichson P, Eldevik P, Gronseth K. Fat infiltration, atrophy and hypertrophy of skeletal muscles demonstrated by X-ray computed tomography in neurological patients. Acta Neurol. Scand. 1988;77:115–122
  11. Bosmans J, Degryse H, Martin JJ, De Schepper A. Myotonic dystrophy (Steinert's disease): CT and MR findings in 16 cases. J. Belge Radiol. 1991;74:481–490
  12. Lamminen AE. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br. J. Radiol. 1990;63:946–950
  13. Schedel H, Reimers CD, Nagele M, Witt TN, Pongratz DE, Vogl T. Imaging techniques in myotonic dystrophy. A comparative study of ultrasound, computed tomography and magnetic resonance imaging of skeletal muscles. Eur. J. Radiol. 1992;15:230–238
  14. Gardner-Medwin D. Clinical features and classification of the muscular dystrophies. Br. Med. Bull. 1980;36:109–115
  15. Spowart G, Buckton KE, Skinner R, Emery AEH. X chromosome in Duchenne muscular dystrophy. Lancet. 1982;I:1251
  16. Nigro G, Comi LI, Limongelli FM, Giugliano MA, Politano L, Petretta V, et al. Prospective study of X-linked progressive muscular dystrophy in Campania. Muscle Nerve. 1983;6:253–262
  17. Bushby KMD, Appleton R, Anderson LVB, Welch JL, Kelly P, Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev. Med. Child Neurol. 1995;37:260–269
  18. Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am. J. Med. Genet. 1999;82:392–398
  19. Bushby KMD. The limb-girdle muscular dystrophies—multiple genes, multiple mechanisms. Hum. Mol. Genet. 1999;8:1875–1882
  20. Padberg GW, Lunt PW, Koch M, Fardeau M. Workshop report: diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromusc. Disord. 1991;1:231–234
  21. Lunt PW, Harper PS. Genetic counseling in facioscapulohumeral muscular dystrophy. J. Med. Genet. 1991;28:655–664
  22. Upadhyaya M, Maynard J, Osborn M, Jardine P, Harper PS, Lunt P. Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD). Muscle Nerve. 1995;Suppl. 2:S45–S49
  23. Sarfarazi M, Wijmenga C, Upadhyaya M, Weiffenbach B, Hyser C, Mathews K, et al. Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am. J. Hum. Genet. 1992;51:396–403
  24. Brouwer OF, Padberg GW, Wijmenga C, Frants RR. Facioscapulohumeral muscular dystrophy in early childhood. Arch. Neurol. 1994;51:387–394
  25. Jardine PE, Upadhyaya M, Maynard J, Harper P, Lunt PW. A scapular onset muscular dystrophy without facial involvement: possible allelism with facioscapulohumeral muscular dystrophy. Neuromusc. Disord. 1994;4:477–482
  26. Hyser CL, Kissel JT, Warmolts JR, Mendell JR. Scapuloperoneal neuropathy: a distinct clinicopathologic entity. J. Neurol. Sci. 1988;87:91–102
  27. Emery AEH. Emery–Dreifuss syndrome. J. Med. Genet. 1989;26:637–641
  28. Yorifuji H, Tadano Y, Tsuchiya Y, Ogawa M, Goto K, Umetani A, et al. Emerin, deficiency of which causes Emery-Dreifuss muscular dystrophy, is localized at the inner nuclear membrane. Neurogenetics. 1997;1:135–140
  29. Manilal S, Sewry CA, Pereboev A, Man N, Gobbi P, Hawkes S, et al. Distribution of emerin and lamins in the heart and implications for Emery–Dreifuss muscular dystrophy. Hum. Mol. Genet. 1999;8:353–359
  30. Vuolteenaho R, Nissinen M, Sainio K, Byers M, Eddy R, Hirvonen H, et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J. Cell Biol. 1994;124:381–394
  31. Philpot J, Cowan F, Pennock J, Sewry C, Dubowitz V, Bydder G, et al. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromusc. Disord. 1999;9:81–85
  32. Brockington M, Sewry CA, Herrmann R, Naom I, Dearlove A, Rhodes M, et al. Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42. Am. J. Hum. Genet. 2000;66:428–435
  33. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type—clinical, genetic and pathological considerations. Brain Dev. 1981;3:1–30
  34. Kondo-Iida E, Kobayashi K, Watanabe M, Sasaki J, Kumagai T, Koide H, et al. Novel mutations and genotype–phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum. Mol. Genet. 1999;8:2303–2309
  35. Goldman A, Ramsay M, Jenkins T. Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats. J. Med. Genet. 1994;31:37–40
  36. Harley HG, Walsh KV, Rundle S, Brook JD, Sarfarazi M, Koch MC, et al. Localisation of the myotonic dystrophy locus to 19q13.2–19q13.3 and its relationship to twelve polymorphic loci on 19q.. Hum. Genet. 1991;87:73–80
  37. Hofmann-Radvanyi H, Junien C. Myotonic dystrophy: over-expression or/and under-expression? A critical review on a controversial point. Neuromuscul. Disord. 1993;3:497–501
  38. Johnson ER, Abresch RT, Carter GT, Kilmer DD, Fowler WM, Sigford BJ, et al. Profiles of neuromuscular diseases: myotonic dystrophy. Am. J. Phys. Med. Rehabil. 1995;74(5 Suppl.):S104–116
  39. Barnes PR. Clinical and genetic aspects of myotonic dystrophy. Br. J. Hosp. Med. 1993;50:22–30
  40. Serratrice G, Salamon G, Jiddane M, Gastaut JL, Pellissier JF, Pouget J. Results of muscular x-ray computed tomography in 145 cases of neuromuscular disease. Rev. Neurol. (Paris). 1985;141:404–412
  41. Glantz RH, Wright RB, Huckman MS, Garron DC, Siegel IM. Central nervous system magnetic resonance imaging findings in myotonic dystrophy. Arch. Neurol. 1988;45:36–37
  42. Damian MS, Bachmann G, Herrmann D, Dorndorf W. Magnetic resonance imaging of muscle and brain in myotonic dystrophy. J. Neurol. 1993;240:8–12
  43. Abdalla JA, Casley WL, Cousin HK, Hudson AJ, Murphy EG, Cornelis FC, et al. Linkage of Thomsen disease to the T-cell-receptor beta (TCRB) locus on chromosome 7q35. Am. J. Hum. Genet. 1992;51:579–584
  44. Ptacek LJ, Trimmer JS, Agnew WS, Roberts JW, Petajan JH, Leppert M. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus. Am. J. Hum. Genet. 1991;49:851–854
  45. Massa R, Weller B, Karpati G, Shoubridge E, Carpenter S. Familial inclusion body myositis among Kurdish-Iranian Jews. Arch. Neurol. 1991;48:519–522
  46. Thomas NH, Dubowitz V. The natural history of type I (severe) spinal muscular atrophy. Neuromusc. Disord. 1994;4:497–502
  47. Ionasescu VV, Trofatter J, Haines JL, Summers AM, Ionasescu R, Searby C. Heterogeneity in X-linked recessive Charcot–Marie-Tooth neuropathy. Am. J. Hum. Genet. 1991;48:1075–1083

PII: S0720-048X(01)00399-0

European Journal of Radiology
Volume 40, Issue 3 , Pages 184-197 , December 2001

Article Tools

* Image Usage & Resolution